Teika Market Share Analysis for July 2026

このページでは企業情報について掲載しています。テイカ製薬株式会社（富山市）は、信頼と安全・安心を提供する総合医薬品メーカーです。医療用医薬品、一般用医薬品、医薬部外品を幅広く取り扱い、QOL向上を目指した製品と創薬研究に注力しています。点眼剤、軟膏剤、貼付剤、内服剤を安定供給。

Health > Biotechnology and Pharmaceuticals

Domainteika.co.jp

Year Founded--

Employees201 - 500

Annual Revenue< $1M

Teika

Teika (including company regionals)

teika.co.jp

See more website traffic and engagement information

Total visits to Teika's top domains

Understand Teika market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

teika.co.jp3.4K

See more with Sales Intelligence

Avg. visit duration in Teika's top domains

Analyze Teika engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

teika.co.jp00:00:35

See more with Sales Intelligence

Avg. pageviews on Teika's top domains

See how Teika keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

teika.co.jp2.00

See more with Sales Intelligence

Teika top competitors by domain

Top similar sites in July 2026, ranked by their affinity

m3.comCompany NameM3Employees> 10001HQJapan, AkasakaAnnual revenue> $1BTotal visits6.4MHealth > Medicine

Top technologies used by Teika

These are the website technologies, by industry, used by Teika top domains

Conversion & Analytics (2)

Google Analytics

Advertising (1)

PubMatic

Mobile (1)

Meta Viewport

Other (1)

Google API

More Technologies

1

See all

News & Signals from Teika

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTeika is developing ophthalmic formulation of TAGX-0003.TAGCyx Biotechnologies and Teika Pharmaceutical announce execution of a joint research and development agreement to develop an ophthalmic formulation of TAGX-0003 for the treatment of dry eye.